Doctor profile · Federal record

Dr. Ray Page, D.O.

Hematology & Oncology Physician (CMS: Medical Oncology) · Weatherford, TX

  • NPI 1669422143
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 35 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
920 Santa Fe Dr
Weatherford, TX 760865864
(817) 759-7000
fax (817) 759-7027
Additional location
800 W Magnolia Ave
Fort Worth, TX 761044611
Mailing address
800 W Magnolia Ave
Fort Worth, TX 761044611

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
February 6, 2025
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #J2247

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1669422143. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
107,197
Distinct HCPCS
10
Medicare allowed
$595,920
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 39,000 27 $1
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 36,480 11 $0
J1453 Injection, fosaprepitant, 1 mg 19,800 26 $0
J0897 Injection, denosumab, 1 mg 3,000 24 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,010 28 $0
J2469 Injection, palonosetron hcl, 25 mcg 1,770 28 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 785 297 $122
99215 Established patient office or other outpatient visit, 40-54 minutes 405 130 $171
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 392 38 $27
96413 Administration of chemotherapy into vein, 1 hour or less 379 51 $123

In context: peer comparison

Among 1 peers in this city , average services per provider: 2,820. This provider delivers 38× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,928
Transactions
70
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 10 $204.38
Astellas Pharma US Inc 4 $169.33
GlaxoSmithKline, LLC. 4 $157.22
PUMA BIOTECHNOLOGY, INC. 5 $156.15
AstraZeneca Pharmaceuticals LP 5 $156.12
Tempus AI, Inc 4 $149.26
Gilead Sciences, Inc. 3 $148.39
Janssen Biotech, Inc. 7 $135.32
Merck Sharp & Dohme LLC 7 $134.42
Blueprint Medicines Corporation 1 $118.68
PFIZER INC. 6 $115.83
Takeda Pharmaceuticals U.S.A., Inc. 3 $75.59
Daiichi Sankyo Inc. 3 $72.10
SOBI, INC 4 $71.93
Lilly USA, LLC 4 $67.71

By nature of payment

Food and Beverage
$2,803
Education
$126

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
581
Patients
123
Total drug cost
$1,934,691
Drug Type Claims Patients Total cost
Anastrozole Generic 105 33 $2,768
Revlimid (Lenalidomide) Brand 66 0 $1,182,169
Eliquis (Apixaban) Brand 54 11 $35,552
Gabapentin Generic 44 12 $495
Prochlorperazine Maleate Generic 38 26 $524
Ondansetron Odt (Ondansetron) Brand 37 26 $492
Prednisone Generic 37 0 $292
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 32 15 $1,417
Abiraterone Acetate Generic 30 0 $36,186
Letrozole Generic 30 0 $595

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Ray Page's medical specialty?
Dr. Ray Page practices Hematology & Oncology Physician in Weatherford, TX.
Where does Dr. Ray Page practice?
Dr. Ray Page practices at 920 Santa Fe Dr, Weatherford, TX 760865864. Office phone: 8177597000.
What is Dr. Ray Page's NPI?
Dr. Ray Page's National Provider Identifier (NPI) is 1669422143, issued by NPPES.
Does Dr. Ray Page accept Medicare assignment?
Yes. Dr. Ray Page accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ray Page commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.